Description |
growth arrest and DNA damage inducible gamma |
retinoic acid receptor alpha |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Automobile speeding propensity ( 30643258)
- Fibrinogen levels ( 28107422 26561523)
- General cognitive ability ( 29844566)
- Hand grip strength ( 29691431)
- Metabolic syndrome ( 31589552)
- Nonsyndromic cleft lip with cleft palate ( 28232668)
- Protein quantitative trait loci ( 18464913)
- Thyroglobulin plasma levels ( 30929638)
|
|
Interacting Genes |
55 interacting genes:
AFAP1L1
APP
ARPC5L
CCNB1
CDK1
CDKN1A
CEP57L1
CRIP2
DDAH2
EEF1A1
EEF1G
EIF3G
ESR1
EZH2
GADD45B
GADD45GIP1
GDF9
HAP1
HP
IKBKG
KAT5
LRIF1
LUC7L
LUC7L2
MAP3K4
MED31
MIDN
PCNA
PDE4DIP
PDIA4
PHAX
PIAS4
PLEKHM1
PPARA
PPARD
PPARG
PPIL1
PTN
PTPRK
RAN
RARA
RBM48
RDH13
REL
RWDD2B
RXRA
SERPINA4
SGK1
SH3GLB1
SH3GLB2
SMARCB1
TRMT2A
TSNAX
UTP14A
ZNF579
|
89 interacting genes:
ACTN4
AKT1
ARID1A
ARID5A
ARNTL
BAG1
BTG1
CCND3
CDK7
CEBPA
CLOCK
CNOT1
COPS2
E2F1
ESR1
FGFR1
FN1
FOXO1
GADD45G
GATA2
HDAC1
HDAC3
HDAC4
HMGA1
HR
IRX4
ITGB1BP2
KAT2B
KDM5A
KLF5
LRIF1
MAPK6
MDM2
MECR
MED1
MED25
MED6
MMS19
NCOA1
NCOA2
NCOA3
NCOA6
NCOR1
NCOR2
NKX2-1
NPAS2
NR0B2
NR1H2
NR1H3
NR2E3
NR3C1
NRBF2
NRIP1
NRIP2
NSD1
PARP1
PHF8
PIN1
PML
PNRC2
POU2F1
PRAME
PRDX6
PRKCA
PSMC5
RXRA
RXRB
RXRG
S100A3
SIRT1
SMARCD3
SNW1
SP1
SPEN
SRC
SRF
STAT5B
TADA3
TEKT4
THRB
TNIP1
TOP2B
TRIB3
TRIM24
TRIP4
UBE3A
UBQLN1
USP7
ZBTB16
|
Entrez ID |
10912 |
5914 |
HPRD ID |
05383 |
06769 |
Ensembl ID |
ENSG00000130222
|
ENSG00000131759
|
Uniprot IDs |
O95257
|
A8K840
A8MUP8
F1D8N9
P10276
Q6I9R7
|
PDB IDs |
2WAL
3FFM
|
1DKF
1DSZ
3A9E
3KMR
3KMZ
4DQM
5K13
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|